Search research articles
Contact Us
Filters
Showing results (151-160 of 212) with videos related to
Page
of 22
Sort By:
The Lancet. Infectious Diseases
|
June 18, 2018
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas, Martin Casapia, Raúl Chuquiyauri, et al.
Cell Reports
|
July 6, 2026
Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site
Fu-Hsuan Ko, Amanda K Lukens, Mariana Laureano de Souza, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Duplication of superoxide dismutase and a mutation in aquaglyceroporin mediates the sensitivity of <i>Plasmodium falciparum</i> to cryptosporin, a natural product derived from <i>Acaromyces ingoldii</i>
Tiantian Jiang, Jennifer E Collins, Jin Woo Lee, et al.
Journal of Medicinal Chemistry
|
June 24, 2010
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria
Bryan K S Yeung, Bin Zou, Matthias Rottmann, et al.
Nature Microbiology
|
September 20, 2016
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim, Gregory LaMonte, Marcus C S Lee, et al.
Trends in Parasitology
|
March 2, 2021
MalDA, Accelerating Malaria Drug Discovery
Tuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Journal of Medicinal Chemistry
|
October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines
Claire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
ACS Infectious Diseases
|
February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> Complex
William Nguyen, Madeline G Dans, Iain Currie, et al.
Cell Host & Microbe
|
June 19, 2012
Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin
Dominic Hoepfner, Case W McNamara, Chek Shik Lim, et al.
Angewandte Chemie (International Ed. in English)
|
October 24, 2025
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum
Henrico Langeveld, Keletso Maepa, Marché Maree, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 212) with videos related to
Sort By:
Page
of 22
The Lancet. Infectious Diseases
|
June 18, 2018
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas, Martin Casapia, Raúl Chuquiyauri, et al.
Cell Reports
|
July 6, 2026
Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site
Fu-Hsuan Ko, Amanda K Lukens, Mariana Laureano de Souza, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Duplication of superoxide dismutase and a mutation in aquaglyceroporin mediates the sensitivity of <i>Plasmodium falciparum</i> to cryptosporin, a natural product derived from <i>Acaromyces ingoldii</i>
Tiantian Jiang, Jennifer E Collins, Jin Woo Lee, et al.
Journal of Medicinal Chemistry
|
June 24, 2010
Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria
Bryan K S Yeung, Bin Zou, Matthias Rottmann, et al.
Nature Microbiology
|
September 20, 2016
UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
Michelle Yi-Xiu Lim, Gregory LaMonte, Marcus C S Lee, et al.
Trends in Parasitology
|
March 2, 2021
MalDA, Accelerating Malaria Drug Discovery
Tuo Yang, Sabine Ottilie, Eva S Istvan, et al.
Journal of Medicinal Chemistry
|
October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines
Claire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
ACS Infectious Diseases
|
February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> Complex
William Nguyen, Madeline G Dans, Iain Currie, et al.
Cell Host & Microbe
|
June 19, 2012
Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin
Dominic Hoepfner, Case W McNamara, Chek Shik Lim, et al.
Angewandte Chemie (International Ed. in English)
|
October 24, 2025
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum
Henrico Langeveld, Keletso Maepa, Marché Maree, et al.
Page
of 22